Lifecare AS Cash Flow Conversion Efficiency

Latest as of June 2026: -0.228x

Lifecare AS cash flow conversion efficiency. Based on the latest financial reports, Lifecare AS (LIFE) has a cash flow conversion efficiency ratio of -0.228x as of June 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Nkr-12.41 Million ≈ $-1.31 Million USD) by net assets (Nkr54.47 Million ≈ $5.73 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Lifecare AS (2017–2025)

Cash flow conversion efficiency of Lifecare AS from 2017 to 2025. This chart illustrates how Lifecare AS's cash flow conversion efficiency has evolved over time, based on yearly financial data. View LIFE share price today for real-time trading data and today's change.

Lifecare AS Cash Flow Conversion Ratio Explained

Lifecare AS cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Lifecare AS Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Lifecare AS ranked by their cash flow conversion efficiency. Also see LIFE market cap for the company's overall valuation and market capitalisation.

Company Cash Flow Conversion Efficiency
Crunchfish AB
ST:CFISH
-0.084x
Quartz Mountain Resources Ltd
V:QZM
-0.198x
BMG Resources Ltd
AU:BMG
-0.022x
Les Enphants Co Ltd
TW:2911
-0.426x
Alphawave IP Group PLC
LSE:AWE
-0.107x
Thai Nondestructive Testing Public Company Limited
BK:TNDT
0.057x
Leeuwin Metals Ltd
AU:LM1
-0.042x
Aqua Corporation Public Company Limited
BK:AQUA
0.005x

Annual Cash Flow Conversion Efficiency for Lifecare AS (2017–2025)

The table below shows the annual cash flow conversion efficiency of Lifecare AS from 2017 to 2025. Review Lifecare AS (LIFE) FCF generation index to assess how much free cash flow the company generates relative to operating cash flow.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-12-31 Nkr-28.02 Million
≈ $-2.95 Million
Nkr-110.37 Million
≈ $-11.61 Million
3.939x +544.67%
2024-12-31 Nkr73.98 Million
≈ $7.78 Million
Nkr-65.54 Million
≈ $-6.90 Million
-0.886x -63.52%
2023-12-31 Nkr66.45 Million
≈ $6.99 Million
Nkr-36.00 Million
≈ $-3.79 Million
-0.542x -67.72%
2022-12-31 Nkr55.25 Million
≈ $5.81 Million
Nkr-17.85 Million
≈ $-1.88 Million
-0.323x +43.13%
2021-12-31 Nkr24.25 Million
≈ $2.55 Million
Nkr-13.77 Million
≈ $-1.45 Million
-0.568x -170.03%
2020-12-31 Nkr13.33 Million
≈ $1.40 Million
Nkr-2.80 Million
≈ $-294.99K
-0.210x +50.64%
2019-12-31 Nkr15.73 Million
≈ $1.66 Million
Nkr-6.70 Million
≈ $-705.49K
-0.426x -41.36%
2018-12-31 Nkr22.24 Million
≈ $2.34 Million
Nkr-6.70 Million
≈ $-705.49K
-0.301x -110.57%
2017-12-31 Nkr-2.35 Million
≈ $-247.41K
Nkr-6.70 Million
≈ $-705.49K
2.852x --

About Lifecare AS

OL:LIFE Norway Medical Devices
Market Cap
$17.83 Million
Nkr169.40 Million NOK
Market Cap Rank
#25320 Global
#237 in Norway
Share Price
Nkr0.42
Change (1 day)
+8.49%
52-Week Range
Nkr0.28 - Nkr5.86
All Time High
Nkr95.08
About

Lifecare ASA, together with its subsidiaries, operates as a medical sensor company that develops technology for sensing and monitoring of various body analytes in Norway and United Kingdom. The company develops Sencell, a 3D printed nano-sensor for monitoring glucose levels in patients with diabetes and for veterinary applications; as well as medical devices that remove subdermal implants. Lifeca… Read more